GGrantIndex
← Leaderboards

Daniel Joseph Conklin

University Of Louisville

$13,454,433
Attributed
$13,574,135
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,574,135 · 10

By mechanism

R01$7,379,732 · 3
P50$2,964,157 · 1
R21$1,179,688 · 2
P30$987,800 · 1
P20$741,205 · 1
T35$179,553 · 1

Top collaborators

Most similar at University Of Louisville

Same institution · by research overlap

Others in their field

Top investigators on “Future

Research focus

FutureMetabolismAnimal ModelCardiovascular SystemEvaluationProductionProgramsMediatingMemberAnimalsMetabolicPhenotypeAffectAcroleinServicesLeadDoctor Of PhilosophyComplexDiabetes MellitusObesityTrainingCardiovascular Disorder RiskCardiacGrant

Grant awards (37)

Cardiopulmonary Toxicity of Electronic Nicotine Delivery Systems$778,558
R01 · FY2025 · HL · contact PI
Summer Environmental Health Sciences Training Program$45,177
T35 · FY2025 · ES
Cardiopulmonary Toxicity of Electronic Nicotine Delivery Systems$778,558
R01 · FY2024 · HL · contact PI
Summer Environmental Health Sciences Training Program$33,448
T35 · FY2024 · ES
Summer Environmental Health Sciences Training Program$51,190
T35 · FY2023 · ES
Animal Models and Phenotyping Core$197,560
P30 · FY2022 · GM · contact PI
Cardiovascular Benefits of Inhaled Biogenic Volatile Organic Compounds$195,625
R21 · FY2022 · ES · contact PI
Cardiovascular Benefits of Inhaled Biogenic Volatile Organic Compounds$234,063
R21 · FY2021 · ES · contact PI
Animal Models and Phenotyping Core$197,560
P30 · FY2021 · GM · contact PI
Summer Environmental Health Sciences Training Program$49,738
T35 · FY2021 · ES
Animal Models and Phenotyping Core$197,560
P30 · FY2020 · GM · contact PI
Cardiovascular Toxicity of Tobacco Products and Constituents$748,154
R01 · FY2019 · HL · contact PI
Animal Models and Phenotyping Core$197,560
P30 · FY2019 · GM · contact PI
Cardiovascular Toxicity of Tobacco Products and Constituents$748,154
R01 · FY2018 · HL · contact PI
Animal Models and Phenotyping Core$197,560
P30 · FY2018 · GM · contact PI
Cardiovascular Toxicity of Tobacco Products and Constituents$748,154
R01 · FY2017 · HL · contact PI
Core B: Tobacco Product Evaluation and Exposure Core$508,121
P50 · FY2017 · HL · contact PI
Core D - Animal Models and Phenotyping Core$148,241
P20 · FY2017 · GM · contact PI
Cardiovascular Toxicity of Tobacco Products and Constituents$748,154
R01 · FY2016 · HL · contact PI
Core B: Tobacco Product Evaluation and Exposure Core$569,143
P50 · FY2016 · HL · contact PI
Core D - Animal Models and Phenotyping Core$148,241
P20 · FY2016 · GM · contact PI
Cardiovascular Toxicity of Tobacco Products and Constituents$748,154
R01 · FY2015 · HL · contact PI
Core B: Tobacco Product Evaluation and Exposure Core$569,521
P50 · FY2015 · HL · contact PI
Core D - Animal Models and Phenotyping Core$148,241
P20 · FY2015 · GM · contact PI
Core B: Tobacco Product Evaluation and Exposure Core$568,907
P50 · FY2014 · HL · contact PI
Novel Treatments of Acrolein-induced Cardiotoxicity$375,000
R21 · FY2014 · ES · contact PI
Core D - Animal Models and Phenotyping Core$148,241
P20 · FY2014 · GM · contact PI
Core B: Tobacco Product Evaluation and Exposure Core$748,465
P50 · FY2013 · HL · contact PI
Novel Treatments of Acrolein-induced Cardiotoxicity$375,000
R21 · FY2013 · ES · contact PI
Core D - Animal Models and Phenotyping Core$148,241
P20 · FY2013 · GM · contact PI
Cardioprotective Mechanisms of Glutathione S-transferase P$366,300
R01 · FY2012 · HL · contact PI
Cardioprotective Mechanisms of Glutathione S-transferase P$370,000
R01 · FY2011 · HL · contact PI
Cardioprotective Mechanisms of Glutathione S-transferase P$370,000
R01 · FY2010 · HL · contact PI
Cardioprotective Mechanisms of Glutathione S-transferase P$370,000
R01 · FY2009 · HL · contact PI
Cardioprotective Mechanisms of Glutathione S-transferase P$235,546
R01 · FY2009 · HL · contact PI
Cardioprotective Mechanisms of Glutathione S-transferase P$370,000
R01 · FY2008 · HL · contact PI
Aldehydes and Coronary Artery Vasospasm$142,000
R15 · FY2002 · ES